当前位置: X-MOL 学术Lancet Infect Dis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Treating malaria: new drugs for a new era
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2017-09-12 , DOI: 10.1016/s1473-3099(17)30475-9
G Dennis Shanks , Jörg J Möhrle

In The Lancet Infectious Diseases, Ousmane Koita and colleagues1 reported the results of a randomised, phase 2, non-inferiority clinical trial. They compared AQ-13, a next generation 4-aminoquinoline (4-AQ) compound, with artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in 66 Malian men.

中文翻译:

治疗疟疾:新时代的新药

《柳叶刀传染病》中,Ousmane Koita及其同事1报告了一项随机的2期非劣效性临床试验的结果。他们比较了下一代4-氨基喹啉(4-AQ)化合物AQ-13与蒿甲醚加色花青素在66例马里男子中治疗单纯性恶性疟原虫的能力
更新日期:2017-09-13
down
wechat
bug